Phototherapeutical apparatus and method for the treatment and prevention of diseases of body cavities
A phototherapeutical apparatus and method are described. The apparatus includes an ultraviolet light source, an optical guidance system, and a patient interface. The patient interface is insertable at least partially into a body cavity and is operable to apply the guided ultraviolet light to a tissue surface of a body cavity. The method includes providing the phototherapeutical apparatus, preparing for the application of the phototherapeutical apparatus, inserting the patient interface at least partially into a body cavity, and applying the ultraviolet light by the patient interface to a tissue surface of a body cavity, wherein the tissue of the body cavity has an inflammatory or a hyperproliferative disease. The inflammatory diseases include rhinitis, sinusitis and rhinosinusitis. A photochemotherapeutical method is also described, using photosensitizing substances, such as psoralen before treatment with ultraviolet light. The phototherapeutical method is also effective for the prevention of inflammatory or hyperproliferative diseases.
1. A phototherapeutical apparatus, comprising:
an ultraviolet multiwavelength light source, operable to generate ultraviolet light with a wavelength in the range of about 280 nm to about 400 nm;
an optical guidance system, operable to receive and guide the ultraviolet light of the light source; and
a patient interface, operable
to receive the guided light from the optical guidance system; and
to be inserted at least partially into a small body cavity, wherein the multiwavelength light source comprises: a quartz bulb, operable to generate ultraviolet light, the quartz bulb comprising:
electrodes, defining a discharge volume of 0.1 mm 3 to 1 mm 3 , coupled to a power supply; and
gas.
2. The phototherapeutical apparatus of claim 1 , wherein the multiwavelength light source comprises:
a concave mirror, reflecting a part of the ultraviolet light generated by the quartz bulb;
a focusing lens, operable to focus a part of the generated ultraviolet light and a part of the reflected ultraviolet light; and
an optical filter, operable to receive and filter the focused light.
3. The phototherapeutical apparatus of claim 1 , wherein the quartz bulb further comprises at least one of a fluorescent lamp, an arc lamp, and an electric discharge wherein the electric discharge lamp comprising at least one of xenon, argon, and mercury vapor.
an ultraviolet multiwavelength light source, selected from the group of a fluorescent lamp, an ultraviolet light emitting diode, a dye laser, an arc lamp, and an electric discharge lamp, the electric discharge lamp comprising at least one of xenon, argon, and mercury vapor, operable to generate ultraviolet light with a wavelength in the range of about 280 nm to about 400 nm;
an optical guidance system, operable to receive and guide the ultraviolet light of the light source; and
a patient interface, operable
to receive the guided light from the optical guidance system; and
to be inserted at least partially into a small body cavity,
the phototherapeutical apparatus comprising an optical coupling unit, wherein the optical coupling unit comprises:
a targeting light source, operable to provide a targeting light;
a dichroic mirror, operable to receive the ultraviolet light and the targeting light, and to direct the received lights in a preset direction; and
a lens system, operable
to receive the directed lights from the dichroic mirror; and
to couple the received directed lights into the optical guidance system;
wherein the patient interface comprises
a handgrip, wherein the optical guidance system is coupled into the handgrip;
an optical tube, receiving the guided ultraviolet light and the guided targeting light, guided by the optical guidance system;
an illuminating light source, operable to provide an illuminating light through a head; and
a mirror, mounted in the optical tube, operable to direct the guided ultraviolet light and the guided targeting light through the head onto the tissue surface of the body cavity, wherein the patient interface comprises
a magnifying lens, positioned to receive a reflected illuminating light, reflected from the tissue surface of the body cavity.
4. A method of treating diseases, the method comprising:
providing a phototherapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system;
preparing for the application of the phototherapeutical apparatus;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance system; and
applying the ultraviolet light by the patient interface to a tissue surface of a small body cavity to deliver a dose in the range of 20–1000 mJ/cm 2 in a time interval of 1–10 minutes, wherein
the tissue of the body cavity has at least one of an inflammatory disease and a hyper-proliferative disease, wherein
the tissue is a mucous membrane and the body cavity is at least one of
a mouth cavity, a throat, an esophagus, a stomach, a small intestine, a large intestine, a gastrointestinal tract, a rectum, an ear, a trachea, a urogenital tract, a portio, a uterus, and a conjunctiva.
5. A method of treating diseases, the method comprising:
providing a phototherapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system;
preparing for the application of the phototherapeutical apparatus;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance system; and
applying the ultraviolet light by the patient interface to a tissue surface of a small body cavity to deliver a dose in the range of 20–1000 mJ/cm 2 in a time interval of 1–10 minutes, wherein
the tissue of the body cavity has at least one of an inflammatory disease and a hyper-proliferative disease, wherein
the tissue is a mucous membrane and the body cavity is at least one of a nasal cavity and a paranasal sinus.
6. The method of claim 5 , wherein the inflammatory disease is at least one of
allergic rhinitis, vasomotor rhinitis, nonallergic eosinophilic rhinitis, rhinosinusitis, and sinusitis.
7. The method of claim 5 , wherein the hyper-proliferative disease is a nasal polyp.
8. A method of treating diseases, the method comprising:
providing a phototherapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system;
preparing for the application of the phototherapeutical apparatus;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance system; and
applying the ultraviolet light by the patient interface to a tissue surface of a small body cavity to deliver a dose in the range of 20–1000 mJ/cm in a time interval of 1–10 minutes, wherein
the tissue of the body cavity has at least one of an inflammatory disease and a hyper-proliferative disease, wherein
the preparation for the application of the photoherapeutical apparatus comprises
determining at least one of a minimal erythema dose and a minimal phototoxicity dose.
9. The method of claim 8 , wherein the applying the ultraviolet light to the tissue surface of the body cavity comprises
applying the ultraviolet light in a dose calculated in relation to at least one of the minimal erythema dosis and the minimal phototoxicity dose.
10. A method of treating diseases, the method comprising:
providing a phototherapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system;
preparing for the application of the phototherapeutical apparatus;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance system; and
applying the ultraviolet light by the patient interface to a tissue surface of a small body cavity to deliver a dose in the range of 20–1000 mJ/cm 2 in a time interval of 1–10 minutes, wherein
the tissue of the body cavity has at least one of an inflammatory disease and a hyper-proliferative disease, wherein the preparation for the application of the photoherapeutical apparatus comprises
applying a photosensitizer substance to the tissue surface, wherein the photosensitizer substance is at least one of 5-methoxypsoralen, 8-methoxypsoralen, and trimethoxysporalen.
11. A method of treating diseases, the method comprising:
providing a phototherapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system;
preparing for the application of the phototherapeutical apparatus;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance system; and
applying the ultraviolet light by the patient interface to a tissue surface of a small body cavity to deliver a dose in the range of 20–1000 mJ/cm 2 in a time interval of 1–10 minutes, wherein
the tissue of the body cavity has at least one of an inflammatory disease and a hyper-proliferative disease, wherein the preparation for the application of the photoherapeutical apparatus comprises
applying a photosensitizer substance to the tissue surface, wherein
the applying the photosensitizer substance comprises
applying the photosensitizer substance to the tissue surface in the form of at least one of a spray and a cream.
12. A method of treating diseases, the method comprising:
providing a phototherapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system;
preparing for the application of the phototherapeutical apparatus;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance svstem; and
applying the ultraviolet light by the patient interface to a tissue surface of a small body cavity to deliver a dose in the range of 20–1000 mJ/cm 2 in a time interval of 1–10 minutes, wherein
the tissue of the body cavity has at least one of an inflammatory disease and a hyper-proliferative disease, wherein the preparation for the application of the photoherapeutical apparatus comprises
applying a photosensitizer substance to the tissue surface, wherein
the applying the photosensitizer substance comprises
applying the photosensitizer substance to the tissue surface in a concentration between approximately 0.0005% and 0.5%.
13. A method of treating diseases, the method comprising:
providing a phototherapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system;
preparing for the application of the phototherapeutical apparatus;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance system; and
applying the ultraviolet light by the patient interface to a tissue surface of a small body cavity to deliver a dose in the range of 20–1000 mJ/cm 2 in a time interval of 1–10 minutes, wherein
the tissue of the body cavity has at least one of an inflammatory disease and a hyper-proliferative disease, wherein
the preparation for the application of the photoherapeutical apparatus comprises
applying a vasoconstrictor substance to the tissue surface.
14. A method of treating diseases, the method comprising:
providing a phototherapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system;
preparing for the application of the phototherapeutical apparatus;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance system; and
applying the ultraviolet light by the patient interface to a tissue surface of a small cavity to deliver a dose in the range of 20–1000 mJ/cm 2 in a time interval of 1–10 minutes, wherein
the tissue of the body cavity has at least one of an inflammatory disease and a hyper-proliferative disease, wherein
the applying the ultraviolet light to the tissue surface comprises
applying the ultraviolet light to the tissue surface repeatedly.
15. The method of claim 14 , wherein the applying the ultraviolet light to the tissue surface repeatedly comprises
applying the ultraviolet light repeatedly with at least one of the same dose and an increasing dose, wherein
the increasing dose increases with 10% to 20% percent per application, depending on the tolerance of the patient.
16. The method of claim 14 , wherein the applying the ultraviolet light to the tissue surface repeatedly comprises
applying the ultraviolet light to the tissue surface once, twice, or three times a week.
17. The phototherapeutical method of claim 14 , wherein an inner diameter of the small body cavity is less than 1 centimeter.
18. A method of treating diseases, the method comprising:
providing a phototherapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system; preparing for the application of the phototherapeutical apparatus; inserting the patient interface at least partially into a nasal cavity;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance system; and
applying the ultraviolet light by the patient interface to a tissue surface of the nasal cavity, wherein
the tissue of the nasal cavity has allergic rhinitis.
19. A method of preventing diseases, the method comprising:
providing a phototherapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system;
preparing for the application of the phototherapeutical apparatus;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance system;
applying the ultraviolet light by the patient interface to a tissue surface of a body cavity, wherein
the tissue of the body cavity is symptom-free.
20. The method of claim 19 , wherein the applying the ultraviolet light by the patient interface comprises
inserting the patient interface at least partially into the body cavity.
21. The method of claim 19 , wherein the preventing diseases comprises
preventing at least one of an inflammatory disease and a hyper-proliferative disease.
22. The method of claim 19 , wherein the preventing diseases comprises
preventing a disease of at least one of a mucous membrane of a nasal cavity and a nasal sinus.
23. The method of claim 19 , wherein the preventing diseases comprises preventing rhinitis allergica.
24. A method of treating diseases, the method comprising:
providing a phototheapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system;
preparing for the application of the phototherapeutical apparatus;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance system; and
applying the ultraviolet light by the patient interface to a tissue surface of a body cavity, wherein
the tissue of the body cavity has at least one of an inflammatory disease and a hyper-proliferative disease; and
the multiwavelength light source is one of a fluorescent lamp, a ultraviolet light emitting diode, a dye laser, an arc lamp, and an electric discharge lamp, the electric discharge lamp comprising at least one of xenon, argon, and mercury vapor, generating a quasi continuous light with a frequency less than about 10 Hertz.
25. A method of treating diseases, the method comprising:
providing a phototherapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system;
preparing for the application of the phototherapeutical apparatus;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance system; and
applying the ultraviolet light by the patient interface to a tissue surface of a body cavity, wherein
the tissue of the body cavity has at least one of an inflammatory disease and a hyper-proliferative disease; and
the tissue is a mucous membrane and the body cavity is at least one of a mouth cavity, a throat, an esophagus, a stomach, a small intestine, a large intestine, a gastrointestinal tract, a rectum, an ear, a trachea, a urogenital tract, a portio, a uterus, a conjunctiva, a nasal cavity and a paranasal sinus.
26. A method of treating diseases, the method comprising:
providing a phototherapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system;
preparing for the application of the phototherapeutical apparatus;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance system; and
applying the ultraviolet light by the patient interface to a tissue surface of a body cavity, wherein
the tissue of the body cavity has at least one of an allergic rhinitis, vasomotor rhinitis, nonallergic eosinophilic rhinitis, rhinosinusitis, sinusitis, and nasal polyp.
27. A method of treating diseases, the method comprising:
providing a phototherapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system;
preparing for the application of the phototherapeutical apparatus;
determining at least one of a minimal erythema dosis and a minimal phototoxicity dosis;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance system; and
applying the ultraviolet light in a dose calculated in relation to at least one of the minimal erythema dosis and the minimal phototoxicity dose by the patient interface to a tissue surface of a body cavity, wherein
the tissue of the body cavity has at least one of an inflammatory disease and a hyper-proliferative disease.
28. A method of treating diseases, the method comprising:
providing a phototherapeutical apparatus, comprising:
an ultraviolet light source;
an optical guidance system, coupled to the ultraviolet light source; and
a patient interface, coupled to the optical guidance system;
preparing for the application of the phototherapeutical apparatus, comprising at least one of:
applying one of 5-methoxypsoralen, 8-methoxypsoralen, and trimethoxysporalen to the tissue surface;
applying a photosensitizer substance to the tissue surface in the form of at least one of a spray and a cream;
applying a photosensitizer substance to the tissue surface in a concentration between approximately 0.0005% and 0.5%; and
applying a vasoconstrictor substance to the tissue surface;
generating ultraviolet light with the ultraviolet light source;
coupling the generated ultraviolet light into the patient interface through the optical guidance system; and
applying the ultraviolet light by the patient interface to a tissue surface of a body cavity, wherein
the tissue of the body cavity has at least one of an inflammatory disease and a hyper-proliferative disease.